Join to view full profile
1275 York AveNew York, NY 10065
Phone+1 212-639-2000
Fax+1 212-305-6762
Dr. Bass is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2005 - 2009- Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2008
Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 2002 - 2005- Mass General Brigham/Massachusetts General HospitalInternship, Internal Medicine, 2002 - 2003
Duke University School of MedicineClass of 2002
Certifications & Licensure
NJ State Medical License 2025 - 2027
NY State Medical License 2020 - 2027
MA State Medical License 2004 - 2021
American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- A dependency map enhanced with next-generation 3D cancer models.James V Neiswender, Samuel Maffa, Lisa Brenan, Dina ElHarouni, Yejie Yun
Nature. 2026-08-05 - 26 citationsRecurrent RhoGAP gene fusion CLDN18-ARHGAP26 promotes RHOA activation and focal adhesion kinase and YAP-TEAD signalling in diffuse gastric cancer.Feifei Zhang, Varun Sahu, Ke Peng, Yichen Wang, Tianxia Li
Gut. 2024-07-11 - 8 citationsRHOAdrives the development of diffuse gastric cancer through IGF1R-PAK1-YAP1 signaling.Antje Schaefer, Richard G Hodge, Haisheng Zhang, G Aaron Hobbs, Julien Dilly
Science Signaling. 2023-12-19
Journal Articles
- Author Correction: Targeting Wild-Type KRAS-Amplified Gastroesophageal Cancer Through Combined MEK and SHP2 InhibitionDaniel Catenacci, Adam J Bass, Shaunt Fereshetian, Rameen Beroukhim, Nature
- Comprehensive Molecular Characterization of Clinical Responses to PD-1 Inhibition in Metastatic Gastric CancerAdam Bass, MD, Nature
Press Mentions
A Case of Mistaken Identity: Researchers Unmask Cellular Source of Barrett’s EsophagusJanuary 13th, 2022- Cancer Center at 50December 23rd, 2021
- State of Stomach Cancer Research and CareNovember 23rd, 2021
Grant Support
- Genome Discovery And Validation In Upper Gastrointestinal CarcinomasNational Cancer Institute2008–2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
